These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 702053)

  • 1. Association of low C2 and C4 serum levels with the HLA-DW2 allele in healthy individuals.
    Nerl C; Grosse-Wilde H; Valet G
    J Exp Med; 1978 Sep; 148(3):704-13. PubMed ID: 702053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.
    Venneker GT; van den Hoogen FH; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; Boerbooms AM; de Waal LP; Bos JD; Asghar SS
    Exp Clin Immunogenet; 1998; 15(2):90-9. PubMed ID: 9691203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [B, C2 and C4 complement factors, the HLA system and diseases. Genetic relation].
    Doutre MS
    Pathol Biol (Paris); 1983 Sep; 31(7):622-30. PubMed ID: 6355995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the C2-deficiency gene (C2*QO) with the C4A*4, C4B*2 genes.
    Hauptmann G; Tongio MM; Goetz J; Mayer S; Fauchet R; Sobel A; Griscel C; Berthoux F; Rivat C; Rother U
    J Immunogenet; 1982 Apr; 9(2):127-32. PubMed ID: 7086154
    [No Abstract]   [Full Text] [Related]  

  • 5. Complement-human histocompatibility antigen haplotypes in C2 deficiency.
    Awdeh ZL; Raum DD; Glass D; Agnello V; Schur PH; Johnston RB; Gelfand EW; Ballow M; Yunis E; Alper CA
    J Clin Invest; 1981 Feb; 67(2):581-3. PubMed ID: 7462431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The location of C2, C4, and BF relative to HLA-B and HLA-D.
    Raum DD; Awdeh ZL; Glass D; Yunis E; Alper CA
    Immunogenetics; 1981 Mar; 12(5-6):473-83. PubMed ID: 7216322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between allotypes of complement components C2, BF, C4 of HLA class III and cerebral stroke.
    Wang C; Zhao XZ; Chen SQ; Wang ZH
    J Tongji Med Univ; 1992; 12(2):90-3. PubMed ID: 1433424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage relationship of C2 deficiency, HLA and glyoxalase I loci.
    Mahowald ML; Dalmasso AP; Petzel RA; Yunis EJ
    Vox Sang; 1979; 37(6):321-8. PubMed ID: 161677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofixation for C2 typing: C2 allotypes in Spaniards in relation to HLA, Bf and C4.
    Regueiro JR; Arnaiz-Villena A
    Hum Genet; 1985; 71(1):58-61. PubMed ID: 3897025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC-linked class III genes. Analysis of C4 gene frequencies, complotypes and associations with distinct HLA haplotypes in German Caucasians.
    Schendel DJ; O'Neill GJ; Wank R
    Immunogenetics; 1984; 20(1):23-31. PubMed ID: 6589207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement genetics in relation to HLA.
    Lachmann PJ; Hobart MJ
    Br Med Bull; 1978 Sep; 34(3):247-52. PubMed ID: 363219
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic polymorphisms of properdin factor B(Bf), the second component (C2), and the fourth component (C4) of complement in leprosy patients and healthy controls from Thailand.
    Greiner J; Weber FJ; Mauff G; Baur M
    Immunobiology; 1980; 158(1-2):134-8. PubMed ID: 6907169
    [No Abstract]   [Full Text] [Related]  

  • 13. Incomplete functional deficiencies of the fourth (C4) and second (C2) components of complement in a patient with linear frontoparietal scleroderma and his family. Deficiencies determined by a gene not linked to human leukocyte antigen system.
    Venneker GT; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; de Waall LP; Bos JD; Asghar SS
    Exp Clin Immunogenet; 1996; 13(2):104-11. PubMed ID: 9063702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA and C4 in subacute sclerosing panencephalitis.
    Harada F; Onisawa S; Suzuki K; Matsumoto H; Sasazuki T
    Tissue Antigens; 1987 Aug; 30(2):73-5. PubMed ID: 3672494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C4 allotyping distinguishes HLA-B14.1 and B14.2 subgroups.
    O'Neill GJ; Mueller-Eckhardt G; Prel L; Schendel DJ
    Immunogenetics; 1984; 19(4):335-41. PubMed ID: 6585348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic basis of acquired C4 deficiency.
    Cream JJ; Olaisen B; Teisberg P; Soler AV; Thompson RA
    Clin Genet; 1979 Nov; 16(5):297-300. PubMed ID: 519900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype study on C4 polymorphism in Japanese. Associations with MHC alleles, complotypes, and HLA-complement haplotypes.
    Tokunaga K; Omoto K; Akaza T; Akiyama N; Amemiya H; Naito S; Sasazuki T; Satoh H; Juji T
    Immunogenetics; 1985; 22(4):359-65. PubMed ID: 3850846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of allotypes of HLA class III (C2, BF and C4) in patients with schizophrenia.
    Wang C; Jian BX; Jiang XD; Zhao XZ
    Chin Med J (Engl); 1992 Apr; 105(4):316-8. PubMed ID: 1618015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HLA genetic linkage group.
    Lamm LU; Petersen GB
    Transplant Proc; 1979 Dec; 11(4):1692-6. PubMed ID: 394428
    [No Abstract]   [Full Text] [Related]  

  • 20. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.
    Fielder AH; Walport MJ; Batchelor JR; Rynes RI; Black CM; Dodi IA; Hughes GR
    Br Med J (Clin Res Ed); 1983 Feb; 286(6363):425-8. PubMed ID: 6401549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.